Literature DB >> 23124233

Poly-γ-(D)-glutamic acid capsule interferes with lytic infection of Bacillus anthracis by B. anthracis-specific bacteriophages.

David Negus1, Jane Burton, Angela Sweed, Romuald Gryko, Peter W Taylor.   

Abstract

The poly-γ-d-glutamic acid capsule of Bacillus anthracis is a barrier to infection by B. anthracis-specific bacteriophages. Capsule expression was found to completely inhibit lytic infection by γ phage, an observation supported by the demonstration that this phage does not elaborate a hydrolase that would facilitate penetration through the protective capsule outer layer.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23124233      PMCID： PMC3553781          DOI： 10.1128/AEM.02682-12

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  24 in total

Review 1.  Phage therapy: a reappraisal of bacteriophages as antibiotics.

Authors:  Jameel M Inal
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2003       Impact factor: 4.291

2.  Specific identification of Bacillus anthracis by means of a variant bacteriophage.

Authors:  E R BROWN; W B CHERRY
Journal:  J Infect Dis       Date:  1955 Jan-Feb       Impact factor: 5.226

Review 3.  The interaction of phage and biofilms.

Authors:  Ian W Sutherland; Kevin A Hughes; Lucy C Skillman; Karen Tait
Journal:  FEMS Microbiol Lett       Date:  2004-03-12       Impact factor: 2.742

4.  Synthetic and complex media for the rapid detection of fluorescence of phytopathogenic pseudomonads: effect of the carbon source.

Authors:  A K Vidaver
Journal:  Appl Microbiol       Date:  1967-11

5.  Synthesis of glutamic acid and glutamyl polypeptide by Bacillus anthracis. II. The effect of carbon dioxide on peptide production on solid media.

Authors:  C B THORNE; C G GOMEZ; R D HOUSEWRIGHT
Journal:  J Bacteriol       Date:  1952-03       Impact factor: 3.490

6.  Bacillus anthracis CapD, belonging to the gamma-glutamyltranspeptidase family, is required for the covalent anchoring of capsule to peptidoglycan.

Authors:  Thomas Candela; Agnès Fouet
Journal:  Mol Microbiol       Date:  2005-08       Impact factor: 3.501

7.  In vitro resistance of Bacillus anthracis Sterne to doxycycline, macrolides and quinolones.

Authors:  I Brook; T B Elliott; H I Pryor; T E Sautter; B T Gnade; J H Thakar; G B Knudson
Journal:  Int J Antimicrob Agents       Date:  2001-12       Impact factor: 5.283

Review 8.  Anthrax.

Authors:  M Mock; A Fouet
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

9.  Genome sequence and gene expression of Bacillus anthracis bacteriophage Fah.

Authors:  Leonid Minakhin; Ekaterina Semenova; Jing Liu; Anatoly Vasilov; Elena Severinova; Tarasii Gabisonia; Ross Inman; Arcady Mushegian; Konstantin Severinov
Journal:  J Mol Biol       Date:  2005-10-03       Impact factor: 5.469

10.  Differential diagnosis of Bacillus cereus, Bacillus anthracis, and Bacillus cereus var. mycoides.

Authors:  E R BROWN; M D MOODY; E L TREECE; C W SMITH
Journal:  J Bacteriol       Date:  1958-05       Impact factor: 3.490
View more
  4 in total

Review 1.  Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.

Authors:  Callum J Cooper; Shazeeda Koonjan; Anders S Nilsson
Journal:  Pharmaceuticals (Basel)       Date:  2018-04-19

Review 2.  The Bacillus anthracis Cell Envelope: Composition, Physiological Role, and Clinical Relevance.

Authors:  Alice Chateau; Sander E Van der Verren; Han Remaut; Antonella Fioravanti
Journal:  Microorganisms       Date:  2020-11-26

Review 3.  Possible use of bacteriophages active against Bacillus anthracis and other B. cereus group members in the face of a bioterrorism threat.

Authors:  Ewa Jończyk-Matysiak; Marlena Kłak; Beata Weber-Dąbrowska; Jan Borysowski; Andrzej Górski
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

4.  Modular prophage interactions driven by capsule serotype select for capsule loss under phage predation.

Authors:  Jorge A M de Sousa; Amandine Buffet; Matthieu Haudiquet; Eduardo P C Rocha; Olaya Rendueles
Journal:  ISME J       Date:  2020-07-30       Impact factor: 11.217
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.